Citation

Tanna N, Tatla T, Winn T, Chita S, Ramdoo K, Batten C, Pitkin J. Pharmacol. Pharm. 2016; 7(2): 89-96.

Copyright

(Copyright © 2016, Scientific Research Publishing)

DOI

10.4236/pp.2016.72012

PMID

unavailable

Abstract

BACKGROUND: This paper reports findings from a literature review undertaken to assess the current evidence base for clinical medication review and falls in older people. This forms part of a larger, organisational supported project design work-stream, where the objectives are to define the operational details for clinical medication review as part of multi-factorial assessment for elderly fallers in the community. Patients will be identified and targeted through an integrated care pathway mapping and elderly patient care screening service.

OBJECTIVE: A review of national and best practice guidance to help our understanding of how clinical medication review could be optimised.

METHODS: A PubMed database search was undertaken with search terms including "elderly" and "falls" and "medicines" followed by study of relevant publications in English and including cited referenced publications within selected papers.

RESULTS: Our findings were that both medication over-use and under-use in the elderly occur frequently and can be harmful. Many drugs commonly used by older persons have not been systematically studied as risk factors for falls. The screening tool of older people's prescriptions (STOPP) and screening tool to alert to right treatment (START), validated for assessment of potentially inappropriate prescribing in the elderly, offer the possibility of provision of a structured clinical medication review to patients, with a need for more research on the impact of the STOPP START interventions on both the rates of falls and risk of falls in the elderly.

Language: en